Literature DB >> 19281186

Alignment-free prediction of a drug-target complex network based on parameters of drug connectivity and protein sequence of receptors.

Dolores Viña1, Eugenio Uriarte, Francisco Orallo, Humberto González-Díaz.   

Abstract

There are many drugs described with very different affinity to a large number of receptors. In this work, we selected drug-receptor pairs (DRPs) of affinity/nonaffinity drugs to similar/dissimilar receptors and we represented them as a large network, which may be used to identify drugs that can act on a receptor. Computational chemistry prediction of the biological activity based on quantitative structure-activity relationships (QSAR) substantially increases the potentialities of this kind of networks avoiding time- and resource-consuming experiments. Unfortunately, most QSAR models are unspecific or predict activity against only one receptor. To solve this problem, we developed here a multitarget QSAR (mt-QSAR) classification model. Overall model classification accuracy was 72.25% (1390/1924 compounds) in training, 72.28% (459/635) in cross-validation. Outputs of this mt-QSAR model were used as inputs to construct a network. The observed network has 1735 nodes (DRPs), 1754 edges or pairs of DRPs with similar drug-target affinity (sPDRPs), and low coverage density d = 0.12%. The predicted network has 1735 DRPs, 1857 sPDRPs, and also low coverage density d = 0.12%. After an edge-to-edge comparison (chi-square = 9420.3; p < 0.005), we have demonstrated that the predicted network is significantly similar to the one observed and both have a distribution closer to exponential than to normal.

Mesh:

Year:  2009        PMID: 19281186     DOI: 10.1021/mp800102c

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  12 in total

Review 1.  In-silico approaches to multi-target drug discovery : computer aided multi-target drug design, multi-target virtual screening.

Authors:  Xiao Hua Ma; Zhe Shi; Chunyan Tan; Yuyang Jiang; Mei Lin Go; Boon Chuan Low; Yu Zong Chen
Journal:  Pharm Res       Date:  2010-03-11       Impact factor: 4.200

2.  FacPad: Bayesian sparse factor modeling for the inference of pathways responsive to drug treatment.

Authors:  Haisu Ma; Hongyu Zhao
Journal:  Bioinformatics       Date:  2012-08-24       Impact factor: 6.937

Review 3.  Structure and dynamics of molecular networks: a novel paradigm of drug discovery: a comprehensive review.

Authors:  Peter Csermely; Tamás Korcsmáros; Huba J M Kiss; Gábor London; Ruth Nussinov
Journal:  Pharmacol Ther       Date:  2013-02-04       Impact factor: 12.310

Review 4.  Artificial intelligence and machine-learning approaches in structure and ligand-based discovery of drugs affecting central nervous system.

Authors:  Vertika Gautam; Anand Gaurav; Neeraj Masand; Vannajan Sanghiran Lee; Vaishali M Patil
Journal:  Mol Divers       Date:  2022-07-11       Impact factor: 3.364

5.  Predicting drug-target interaction networks based on functional groups and biological features.

Authors:  Zhisong He; Jian Zhang; Xiao-He Shi; Le-Le Hu; Xiangyin Kong; Yu-Dong Cai; Kuo-Chen Chou
Journal:  PLoS One       Date:  2010-03-11       Impact factor: 3.240

6.  The Mycobacterium tuberculosis drugome and its polypharmacological implications.

Authors:  Sarah L Kinnings; Li Xie; Kingston H Fung; Richard M Jackson; Lei Xie; Philip E Bourne
Journal:  PLoS Comput Biol       Date:  2010-11-04       Impact factor: 4.475

Review 7.  Drug target inference through pathway analysis of genomics data.

Authors:  Haisu Ma; Hongyu Zhao
Journal:  Adv Drug Deliv Rev       Date:  2013-01-28       Impact factor: 15.470

8.  Fragment-based optimization of small molecule CXCL12 inhibitors for antagonizing the CXCL12/CXCR4 interaction.

Authors:  Joshua J Ziarek; Yan Liu; Emmanuel Smith; Guolin Zhang; Francis C Peterson; Jun Chen; Yongping Yu; Yu Chen; Brian F Volkman; Rongshi Li
Journal:  Curr Top Med Chem       Date:  2012       Impact factor: 3.295

9.  SimBoost: a read-across approach for predicting drug-target binding affinities using gradient boosting machines.

Authors:  Tong He; Marten Heidemeyer; Fuqiang Ban; Artem Cherkasov; Martin Ester
Journal:  J Cheminform       Date:  2017-04-18       Impact factor: 5.514

Review 10.  Towards structural systems pharmacology to study complex diseases and personalized medicine.

Authors:  Lei Xie; Xiaoxia Ge; Hepan Tan; Li Xie; Yinliang Zhang; Thomas Hart; Xiaowei Yang; Philip E Bourne
Journal:  PLoS Comput Biol       Date:  2014-05-15       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.